Morepen Laboratories (BOM:500288) Net Income From Continuing Operations : ₹1,180 Mil (TTM As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Morepen Laboratories Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Morepen Laboratories's net income from continuing operations for the three months ended in Mar. 2025 was ₹203 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹1,180 Mil.

Morepen Laboratories Net Income From Continuing Operations Historical Data

The historical data trend for Morepen Laboratories's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories Net Income From Continuing Operations Chart

Morepen Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income From Continuing Operations

Get a 7-Day Free Trial

985.12

1,267.03

557.55

1,354.16

1,551.09

Morepen Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															287.41	361.68	348.49	266.89	203.10

Morepen Laboratories Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,180 Mil.

Morepen Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (BOM:500288) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

MOREPENLAB:India

Address

Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016

Website

https://www.morepen.com

Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.

Morepen Laboratories Headlines

No Headlines